Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Autoimmune optic neuritis].

E Kerty1, N O Aanonsen, R Nyberg-Hansen

  • 1Nevrologisk avdeling, Rikshospitalet, Oslo.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|January 30, 1992
PubMed
Summary

Two patients experienced severe vision loss from autoimmune optic neuritis, a condition distinct from multiple sclerosis. Early, high-dose corticosteroid treatment may restore vision, with cytotoxic agents potentially needed for ongoing management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does cardiovascular autonomic dysfunction contribute to fatigue in myasthenia gravis?

Physiological research·2022
Same author

Juvenile myasthenia gravis in Norway: HLA-DRB1*04:04 is positively associated with prepubertal onset.

PloS one·2017
Same author

Juvenile myasthenia gravis in Norway: Clinical characteristics, treatment, and long-term outcome in a nationwide population-based cohort.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2017
Same author

Juvenile myasthenia gravis in Norway: A nationwide epidemiological study.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2016
Same author

The investigation of inborn errors of metabolism as an underlying cause of idiopathic intellectual disability in adults in Norway.

European journal of neurology·2015
Same author

EFNS/ENS Guidelines for the treatment of ocular myasthenia.

European journal of neurology·2014

Area of Science:

  • Ophthalmology
  • Neurology
  • Rheumatology

Background:

  • Autoimmune optic neuritis can present with severe vision loss without systemic signs.
  • Distinguishing it from idiopathic optic neuritis and multiple sclerosis is crucial.

Observation:

  • Two patients presented with recurrent optic neuritis and significant visual impairment.
  • Conventional corticosteroid doses were insufficient for symptom management.
  • A positive antinuclear antibody (ANA) was the sole indicator of autoimmune disease.

Findings:

  • Autoimmune optic neuritis can cause permanent visual impairment despite standard treatment.
  • Early diagnosis and aggressive corticosteroid therapy are vital for visual recovery.
  • Cytotoxic agents may be necessary for long-term management of autoimmune optic neuritis.

Implications:

  • This case highlights the importance of considering autoimmune optic neuritis in patients with unexplained vision loss.
  • Aggressive treatment strategies, including high-dose corticosteroids and cytotoxic agents, may be required.
  • Further research is needed to understand the long-term prognosis and optimal management of this condition.

Related Experiment Videos